Takeda to buy Millennium for $8.8 billion
Takeda Pharmaceutical of Japan has announced plans to purchase US biotech firm Millennium Pharmaceuticals in a deal valued at nearly $9 billion.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.